Medicine & Health

A community-based rehabilitation program may be an effective way to provide services to people with disabilities even in places with conflict such as Afghanistan, finds a new study from the Brown School and the School of Medicine at Washington University.

The single-year health burden associated with physical intimate partner violence in the South American country of Columbia was $90.6 million, finds a new study from the Brown School at Washington University in St. Louis.

A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

Researchers at Washington University School of Medicine have found that although there have been steady increases in the number of people nationwide who die by suicide, such increases have slowed in states that have implemented Medicaid expansion.

New analysis of the Adolescent Brain Cognitive Development Study by Ryan Bogdan’s lab in Arts & Sciences finds no link to depression in children with prenatal exposure to selective serotonin reuptake inhibitors (SSRI) drugs.

A study from the Washington University School of Medicine shows that treatment with the immunity boosting protein interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells.

A new study from researchers at Washington University School of Medicine and colleagues at other institutions details a new tool that can quickly identify the presence of Ebola virus in blood samples. The technology has potential to be developed into a rapid diagnostic test.

Polina V. Lishko, a noted molecular biologist and entrepreneur, has been named a BJC Investigator at Washington University School of Medicine.

Gregory D. Longmore, MD, at the School of Medicine, and Amit Pathak, at the McKelvey School of Engineering, will study the cells that lead the migration of deadly tumor cells through the body with a five-year $2.54 million National Institutes of Health (NIH) grant.

A network survey among agencies that address cancer risk in rural Missouri and Illinois, conducted by the Brown School and the School of Medicine’s Implementation Science Center for Cancer Control, was found to be useful in helping those practitioners identify gaps, plan for how to establish future relationships and strengthen collaboration.